[New name and new treatments for primary biliary cholangitits].

ABSTRACT

The name of chronic liver disease primary biliary cirrhosis, has been changed to primary biliary cholangitis, primarily because of the stigma associated with the word "cirrhosis", as only a minority of the patients develop cirrhosis. In this review we present data on epidemiology and discuss the current treatments with focus on ursodeoxycholic acid and the newly described effects of the farnesoid receptor agonist obeticholic acid.